Dominic Piscitelli

Dominic Piscitelli is an experienced finance professional currently serving as an Independent Board Member and Audit Committee Chair at Alterome Therapeutics, Inc. since April 2024, and as Chief Financial Officer at ORIC Pharmaceuticals since September 2019. Additional roles include Board Member at Celyad and previously Chief Financial Officer at AnaptysBio from January 2017 to September 2019. Prior experience encompasses Vice President of Finance, Strategy and Investor Relations at Medivation from 2012 to January 2017, and various senior finance roles at Astellas Pharma from 2001 to 2012, including Senior Director of Global Finance and Vice President of Treasury and Management Finance. Early career experience includes serving as an Audit Manager at KPMG Audit from 1996 to 2001. Dominic Piscitelli holds a Master's degree in Accounting and Finance from Hofstra University, where education was completed from 1992 to 1996.